Tweets
Best of 2023: 25 Great Women in Rheumatology
https://t.co/9WgGbpILGb https://t.co/YN8QAHtyab
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
NEJM - Clinical Images. Sleeve Sign and Inverse Gottron’s Papules in Anti-MDA5 Dermatomyositis. Erythematous plaques/patches on lateral aspects upper arms &; red patches, papules, pustules on ventral palms https://t.co/UHKGePi6TK
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
Livedo reticularis is a painless, cyanotic cutaneous mottling in a fishnet pattern, often on extremities > trunk & exaggerated by cold. NOT specific but may be assoc w/ fibromyalgia, Raynauds, atheromatous or autoimmune Dz, hyperviscosity, thrombotic Dz https://t.co/8tGz1hIDiA https://t.co/3mw2RwTEeL
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
- High mortality risk predictors in patients with anti-MDA5 dermatomyositis include:
- rapidly progressive interstitial lung disease
- anti-Ro52 antibody
- age > 57 years
(based on study of 126 MDA-5+ DM pts)
https://t.co/8bw1zpEOIh https://t.co/LKXMYtr7hU
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
DA Approves Canakinumab for Gout Flares The US FDA has approved canakinumab \ Ilaris\ for the treatment of gout flares in adults who cannot be treated with NSAIDs, colchicine, or repeated courses of corticosteroids. https://t.co/OX3wIajQtm https://t.co/tMDMc8ZKE8
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
Great content. Dr Andrea Fava will present this data and other research on lupus biomarkers at https://t.co/2dcFVgu8z6 on Jan 27, 2024. Can't wait! https://t.co/IOJIyDAmeG
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
2022 ACR Classification Criteria for GCA: \ must be \>50yrs\ 6 points needed for #GCA AM stiff should/neck 2 Visual loss 3 Jaw Claud 2 Temp HA 2 Scalp tender 2 Hi ESR/CRP 3 Bx or US 5 axillary 2 PEG Aorta 2 https://t.co/LfkIZKnLZi https://t.co/LdQOoRfG5V
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
RHEUMATOLOGIST SURVEY QUESTION: Is TYK2 part of the Janus Kinase family?
Click here to answer >> https://t.co/Uzad4Tp7YV
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
ICYMI: Effective Treatments for Rheumatoid Arthritis ILD
The ACR guidelines for the diagnosis and management of interstitial lung disease, which includes RA-ILD, has been one of the most controversial topics in the runup to ACR Convergence.
https://t.co/tvXEeaTbRq https://t.co/Dq3NcSAGhf
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
RheumNow Podcast – Bill of Rights
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow. Two major reports on fatigue and fibromyalgia misfired, and "ankylosing spondylitis" is sent to the Rheumatology dead word cemetery.
https://t.co/lYtunY4cqd https://t.co/yNPqhPx5y3
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
Gender Gap Confirmed for TNF Inhibitor Response in Axial SpA
Men with axial spondyloarthritis (axSpA) were more likely than women to obtain substantial relief with tumor necrosis factor (TNF) inhibitors, a multinational study indicated.
https://t.co/ye5iReGLMG https://t.co/goKe0TuYqz
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
Empathy is the hard part.
The rest is mechanics. We're not wired to walk in someone else's shoes, it's not our first instinct.
Showing up with empathy is difficult, hard to outsource and will wear you out. But it's precisely what we need from you. - Seth Godin… https://t.co/U8Ou3WwBmC https://t.co/C4aAVovHDH
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago


